Data protection Impressum

Digital Health

Impli, the deeptech company developing continuous molecular monitoring for hormonal health and present at Biopôle in Lausanne, has been awarded a GBP 1.4 million grant to bring its hormone-monitoring patch toward clinical validation for in vitro fertilization.

Impli secures GBP 1.4 million grant to advance continuous hormone monitoring for IVF

16 June 2026

Geneva-based femtech start-up TrialHer has converted early demand into paid pilots with two companies in the UK and Europe, and was selected to join the WHO/Europe Public Health Innovation Platform.

Geneva femtech TrialHer secures first paid pilots and WHO selection

15 June 2026

Geneva-based MindMaze Therapeutics announced a CHF 8 million strategic equity financing from Neuro.io Group, funding the expansion of its U.S. commercial operations and opening the door to a potential combination of neurotherapeutics and artificial intelligence.

MindMaze secures CHF 8 million to expand its neurotherapeutics platform

1 June 2026

Two Vaud start-ups receive SDSC backing for AI projects, as Neurosoft gains access to the Alps supercomputer for neural AI training.

Western Switzerland steps up support for AI-driven innovation

18 May 2026

Three Geneva-based start-ups have received seed funding through the FONGIT Innovation Fund (FIF), supporting innovations in olfactory diagnostics, AI-powered maritime chartering, and SME cybersecurity.

Geneva backs three start-ups tackling smell, shipping, and cyber threats

27 April 2026

The applied research partnership between CSEM, the Insel Gruppe, and the University of Bern has been extended for three years, building on 32 medtech projects launched since 2023 and reinforcing Bern's ambition to become a leading international medical hub by 2030.

CSEM, Insel Gruppe, and University of Bern extend Bern medtech collaboration for three more years

20 April 2026

Geneva-based dEEGtal has appointed neurotechnology entrepreneur and investor Ann Bunnenberg to its board of directors, as the AI-powered brain signal platform advances clinical studies across Switzerland, Spain, and the United States ahead of a CHF 4–5 million seed round.

dEEGtal strengthens governance and advances clinical validation across three continents

14 April 2026

Four life sciences projects were recognized at BIND – BioInnovation Day 2026, held at CHUV Lausanne on 1 April 2026, as the region's flagship academic innovation showcase drew 340 participants from academia, healthcare, industry, and investment.

BIND 2026 highlights Western Switzerland’s life sciences innovation pipeline

14 April 2026

As life sciences companies navigate increasingly complex global markets, the decision of where to establish or expand international operations has become a strategic one.

Why Life Sciences Companies Choose Switzerland to Scale Internationally

Lausanne-based Xsensio has closed an oversubscribed USD 7 million Series A financing round to accelerate clinical deployment of its Lab-on-Skin wearable biosensing platform, with new backing from WI Harper and a collaboration with Texas Instruments.

Xsensio raises USD 7 million to advance its wearable biosensing platform

3 March 2026

1 2 3 4 5 … 12